Oliver was a co-founder of Biognosys in 2008 and is leading the company as CEO, starting as a spin-off from ETH Zurich to a market-leading inventor and provider of proteomics technology that Biognosys is today.
Karel Novy, PhD
Chief Operating Officer
Karel joined Biognosys in 2016 and held positions of increasing responsibility in Business Development and Scientific Operations. As COO Karel is responsible for the Operations department focusing on contract research projects.
Kristina Beeler, PhD
Chief Business Officer
Kristina leads the business activities of the services offering of Biognosys. Her team enables Biognosys’ global partners to utilize proteomics to address the key challenges in their research.
Lidia Novak, CFA
Chief Financial Officer
Lidia joined Biognosys as CFO in 2018 and is in charge of finance functions including assessment of strategic initiatives and relations with existing and potential investors.
Lukas Reiter, PhD
Chief Technology Officer
Lukas joined Biognosys among the first employees in 2010. As CTO, he oversees research as well as product and workflow development. He has authored key publications in computational proteomics and is a co-inventor of the SWATH technology.
Sira Echevarría Zomeño, PhD
Head of Business Development - Products
Sira is responsible for Biognosys’ products business development and sales, and our customer success. Her team is committed to enabling researchers and mass spectrometry users to apply state-of-the-art proteomics technologies to their research.
Ben Gonzales, MBA
Head of Sales, North America
Ben Gonzales comes with a history of life science and proteomics commercial development with a track record of successfully growing products and services business. As Head of Sales, North America, Ben will be responsible for growing the business and the team in the North American market, in support of Biognosys’ contract research offerings.
Amaury Lachaud, PhD
Head of Sales, Europe & Asia
Amaury joined Biognosys in 2020 and leads the proteomic service commercial team in Europe and Asia. He brings over 13 years of experience in life science and human diagnostic industry, primarily in sales leadership and business unit management roles.
Head of Marketing and Communications
Yves leads the marketing and communications team at Biognosys, which is focused on raising awareness and adoption of Biognosys’ next-generation proteomics platforms and solutions across the services, software and kits markets.
Nadine Frankenberg, PhD
Head of Quality Assurance
Nadine is responsible for quality assurance in all GLP and GCP studies. She has more than 15 years of experience in several quality roles in the pharmaceutical industry and a strong background in GMP, GCP, GLP and ISO17025. Nadine is a board member of the GQMA (German Quality Management Association), dedicated to quality management in the chemical and pharmaceutical industries.
Scientific Advisory Board
Prof. Dr. Ruedi Aebersold
Ruedi, a co-founder of Biognosys, is one of the pioneers in the field of proteomics. He serves on the Scientific Advisory Committees of numerous academic and private-sector research organizations and is a member of several editorial boards in the fields of protein science, genomics, and proteomics.
Johan, Associate Professor at the University of Lund, Sweden, obtained his PhD in a collaboration between Lund University and AstraZeneca R&D Lund. In 2001 he co-founded Ludesi AB. In 2003, Johan joined the Institute for Systems Biology in Seattle, and in 2004, he transferred to the Aebersold lab at the ETH Zurich, where he was involved in the development and application of targeted proteomics technologies and co-founded Biognosys.
Paola obtained her PhD from the University of Padova. In 2006, she joined Prof. Ruedi Aebersold’s group at ETH Zurich, where her research received the ETH Latsis Prize 2011. At the beginning of 2011, she started her own research group and in 2017 she was appointed professor at the Institute of Molecular Systems Biology at ETH Zurich.